02.11.2021 12:22:25
|
IDEXX Labs Lifts FY21 Earnings View; Tightens Revenue Forecast
(RTTNews) - While announcing higher third -quarter results, IDEXX Laboratories, Inc. (IDXX), a veterinary diagnostics provider, raised its forecast for fiscal 2021, inline or below market estimates. Further, the company tightened revenues outlook.
The company now expects full-year earnings per share of $8.30 - $8.38, higher than previous estimate of $8.20 - $8.36. Earnings per share for the year is now expected to grow 24 percent to 25 percent from last year on a reported basis and 26 percent to 27 percent on a comparable basis.
The company previously expected earnings per share for the year to grow 22 percent to 25 percent from last year.
Further, the company now expects revenues of $3.185 billion to $3.200 billion, compared to earlier expected $3.170 billion to $3.205 billion.
On average, analysts polled by Thomson Reuters expect earnings of $8.38 per share on revenues of $3.2 billion. Analysts' estimates typically exclude special items.
The updated view now reflects revenue growth of 17.5 percent to 18 percent on a reported basis and 15.5 percent to 16 percent organic. The previous expectations were reported growth of 17 percent to 18.5 percent and organic growth of 14.5 percent - 16 percent.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IDEXX Laboratoriesmehr Nachrichten
Analysen zu IDEXX Laboratoriesmehr Analysen
Aktien in diesem Artikel
IDEXX Laboratories | 398,50 | -1,26% |